Who
Robert E. Bancroft
President & CEO
Company insider
Files Form 4 as: President & CEO, AEON Biopharma.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Apr 2025
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —3,000,000 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —177,103 at $0.00 | filing |
| 29 Apr 2025filed 1 May 2025 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —59,034 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.